|
Additional information: section a-3b patient gender: female section a-4 patient weight: unknown/asked information was not provided.Section a-5 patient ethnicity: unknown/asked information was not provided.Section a-6 patient race: unknown/asked information was not provided.Section b-3 date of event: unknown/asked information was not provided.The best date estimation is between 05-jun-2025 and 06-nov-2025 (iol implant and explant dates).Section h-3 device evaluated by manufacturer: the complaint device was not returned for evaluation.Therefore, a failure analysis of the complaint device cannot be completed.A review of records including device history and complaint trending will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch report will be filed.All pertinent information available to johnson and johnson surgical vision, inc.Has been submitted.
|
|
The drn00v model intraocular lens (iol) was implanted in the patient¿s ocular sinister (left eye).Post-operatively, the patient reported her vision has never felt good since the initial surgery.She has always noticed a "fuzz" around the edge of her vision and wished her vision was better, eye fatigue sensation, and her daily activities were significantly affected.The iol was explanted during a secondary surgical procedure; the information regarding the replacement iol was not provided.There was no medical attention, no sutures, and no vitrectomy during the lens exchange procedure.Patient's vision pre-operative was 20/30-2 and described as fuzzy, post-operative results were not provided.Patient prognosis post lens exchange is unknown.The iol directions for use were followed.No further information is available.
|